Structural inequities in the availability of prostate cancer clinical trial opportunities
JNCI: Journal of the National Cancer Institute · 01.09.2025 · 117 (9) · 1934-1937
DOI: 10.1093/jnci/djaf047 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 26.02.2025. Verfasst von Rishi Robert Sekar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Michigan, Ann Arbor, MI 48109, United States. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Clinical Trials as Topic, Healthcare Disparities, Social Determinants of Health. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: National Cancer Institute Training.
Abstract (Originalsprache)
Prostate cancer is marked by vast disparities in clinical outcomes for minoritized and socioeconomically disadvantaged populations. We aimed to evaluate the geographic distribution of prostate cancer clinical trial opportunities relative to prostate cancer mortality and social determinants of health by performing an ecological analysis of linked county-level prostate cancer clinical trial data, epidemiologic data, and the Centers for Disease Control and Prevention Social Vulnerability Index. On analysis of 1575 counties in the United States with available data, increasing Social Vulnerability Index was associated with an increase in prostate cancer mortality (+17.88, 95% confidence interval [CI] = 14.16 to 21.61; P < .001), lower odds of having any trial (odds ratio [OR] = 0.14, 95% CI = 0.09 to 0.23; P < .001), and fewer population-adjusted trials (incidence rate ratio = 0.27, 95% CI = 0.19 to 0.40; P < .001). Identifying communities experiencing adverse social determinants of health for expansion of clinical trial opportunities and mitigation of barriers may be an impactful strategy toward improving equity in clinical trials and cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, University of Michigan, Ann Arbor, MI 48109, United States.
- Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI 48109, United States.
- National Clinician Scholars Program.
- Department of Urology, University of California San Francisco, San Francisco, CA 94143, United States.
ORCID-Profile: Rishi Robert Sekar, Laura Zebib, Kristian Donald Stensland
Förderung
- National Cancer Institute Training
Zitieren
APA
Sekar, R. R., Zebib, L., Stensland, K. D., & Herrel, L. A. (2025). Structural inequities in the availability of prostate cancer clinical trial opportunities. JNCI: Journal of the National Cancer Institute, 117(9), 1934-1937. https://doi.org/10.1093/jnci/djaf047
Vancouver
Sekar RR, Zebib L, Stensland KD, Herrel LA. Structural inequities in the availability of prostate cancer clinical trial opportunities. JNCI: Journal of the National Cancer Institute. 2025;117(9):1934-1937. doi:10.1093/jnci/djaf047
BibTeX
@article{Sekar2025,
author = {Sekar, Rishi Robert and Zebib, Laura and Stensland, Kristian Donald and Herrel, Lindsey Allison},
title = {Structural inequities in the availability of prostate cancer clinical trial opportunities},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
volume = {117},
number = {9},
pages = {1934--1937},
doi = {10.1093/jnci/djaf047}
}
EUVIMED